UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013326 |
|---|---|
| Receipt number | R000013962 |
| Scientific Title | Japan PHarmacological Audit study of Safety and Efficacy in Real world |
| Date of disclosure of the study information | 2014/03/04 |
| Last modified on | 2021/03/10 11:58:08 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Japan PHarmacological Audit study of Safety and Efficacy in Real world
Acronym
Phase-R
Scientific Title
Japan PHarmacological Audit study of Safety and Efficacy in Real world
Scientific Title:Acronym
Phase-R
Region
| Japan |
Condition
Condition
Cancer
Classification by specialty
| Not applicable |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the efficacy and safety of symptom management procedures in palliative care setting.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
patient-reported symptom severity
Key secondary outcomes
1) proxy-rated symptom severity
2) adverse event
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Patients with pathologically or clinically diagnosed cancer
2) In- and out-patients receiving palliative care by palliative care team or at palliative care unit
Key exclusion criteria
none
Target sample size
850
Research contact person
Name of lead principal investigator
| 1st name | Isseki |
| Middle name | |
| Last name | Maeda |
Organization
Osaka University Graduate School of Medicine
Division name
Department of Palliative Medicine
Zip code
565-0871
Address
2-2 Yamadaoka, Suita, Osaka
TEL
06-6879-3867
maeda@pm.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Chieko |
| Middle name | |
| Last name | Suzuki |
Organization
Seirei Mikatahara Hospital
Division name
Palliative and Supportive care Division
Zip code
433-8558
Address
3453 Mikatahara, Kita, Hamamatsu, Shizuoka
TEL
053-436-1251
Homepage URL
jmmorita@sis.seirei.or.jp
Sponsor or person
Institute
Department of Palliative Medicine, Osaka University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Japan Hospice Palliative Care Foundation
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Osaka University Graduate School of Medicine
Address
2-2 Yamadaoka, Suita, Japan
Tel
06-6879-3867
maeda@pm.med.osaka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
大阪大学大学院（大阪府）
聖隷浜松病院（静岡県）
聖隷三方原病院（静岡県）
佐久総合病院（長野県）
独立行政法人 国立がん研究センター東病院（千葉県）
三井記念病院（東京都）
川崎市立井田病院かわさき総合ケアセンター（神奈川県）
筑波メディカルセンター病院（茨城県）
ガラシア病院（大阪府）
六甲病院（兵庫県）
九州がんセンター（福岡県）
国立病院機構 近畿中央胸部疾患センター（大阪府）
神戸大学大学院（兵庫県）
島根大学医学部附属病院（島根県）
小牧市民病院（愛知県）
聖路加国際病院（東京都）
東京大学医学部附属病院（東京都）
東京大学医科学研究所附属病院（東京都）
名古屋市立大学大学院（愛知県）
岡山大学病院（岡山県）
国立がん研究センター中央病院（東京都）
千葉県がんセンター（千葉県）
埼玉県立がんセンター（埼玉県）
東京医科歯科大学大学院医歯学総合研究科（東京都）
埼玉医大国際医療センター（埼玉県）
福山市民病院（広島県）
滋賀医科大学（滋賀県）
市立札幌病院（北海道）
相良病院（鹿児島県）
栃木県立がんセンター（栃木県）
近畿大学医学部附属病院（大阪府）
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 03 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 10 | Month | 03 | Day |
Date of IRB
| 2014 | Year | 02 | Month | 01 | Day |
Anticipated trial start date
| 2014 | Year | 02 | Month | 01 | Day |
Last follow-up date
| 2018 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
1) patient-reported symptom severity
2) proxy-rated symptom severity
3) adverse event
Management information
Registered date
| 2014 | Year | 03 | Month | 04 | Day |
Last modified on
| 2021 | Year | 03 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013962
